What is clinically significant RLS and who decides about its treatment?
Berger
Klaus
K
D003430:Cross-Sectional Studies; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000819:agonists; D006801:Humans; D012148:Restless Legs Syndrome / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology
D004295:Dihydroxyphenylalanine